UK markets open in 7 hours 44 minutes
  • NIKKEI 225

    29,188.17
    +679.62 (+2.38%)
     
  • HANG SENG

    28,755.34
    +133.42 (+0.47%)
     
  • CRUDE OIL

    61.89
    +0.46 (+0.75%)
     
  • GOLD FUTURES

    1,785.00
    +3.00 (+0.17%)
     
  • DOW

    33,815.90
    -321.41 (-0.94%)
     
  • BTC-GBP

    37,572.38
    -2,217.76 (-5.57%)
     
  • CMC Crypto 200

    1,194.54
    -48.51 (-3.90%)
     
  • ^IXIC

    13,818.41
    -131.81 (-0.94%)
     
  • ^FTAS

    3,965.04
    +29.40 (+0.75%)
     

Global Spatial Genomics and Transcriptomics Market to Reach $275.8 Million by 2027

ReportLinker
·21-min read

Project Details: - StrategyR - A Trademark of Global Industry Analysts, Inc. - Project Edition: 6. - Influencer Pool: 909. - MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies.

New York, March 18, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Spatial Genomics and Transcriptomics Industry" - https://www.reportlinker.com/p06032958/?utm_source=GNW
In addition to being a global intelligence exchange platform, MarketGlass™ is a powerful knowledge center that delivers dynamic project-focused market intelligence. Client companies will have complete insider access to the project Data stack.
- Interactive peer-to-peer and enterprise-to-enterprise ideation and market intelligence exchange is facilitated via a robust, secure, and validated process. The process draws from uniquely qualified project-specific and geographically focused executives overseeing business development, marketing and sales operations.

  • Trends & Factors - Identifying and validating local trends and factors driving each competitive marketplace. These factors include pricing variances, market trajectories, Covid-19 impact and recovery, locally active leading brands, and other parameters impacting the region in the short to medium term such as supply chain realignments.

  • Mobile Access & App - Our mobile version of the report may be accessed via our mobile app or directly for a full mobile experience.

  • Complimentary Updates - for one year. At least one update in 12-month period is normal and anytime there’s a significant change affecting the market dynamics.

  • Bespoke Updates & Team Collaborations - Clients may build a bespoke version of our report with peers on our MarketGlass™ platform which enables multidimensional data simulations.

  • Knowledge Center - clients have full-stack data access for project data they support or purchase including primary research engagement stats, companies and executives.



Abstract:
- Global Spatial Genomics and Transcriptomics Market to Reach $275.8 Million by 2027
- Amid the COVID-19 crisis, the global market for Spatial Genomics and Transcriptomics estimated at US$170.7 Million in the year 2020, is projected to reach a revised size of US$275.8 Million by 2027, growing at a CAGR of 7.1% over the analysis period 2020-2027. Consumables, one of the segments analyzed in the report, is projected to record a 7.5% CAGR and reach US$143.4 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Instruments segment is readjusted to a revised 6.4% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $50.4 Million, While China is Forecast to Grow at 6.6% CAGR
- The Spatial Genomics and Transcriptomics market in the U.S. is estimated at US$50.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$48.2 Million by the year 2027 trailing a CAGR of 6.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.7% and 5.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.
- Software Segment to Record 7.1% CAGR
- In the global Software segment, USA, Canada, Japan, China and Europe will drive the 7.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$28.7 Million in the year 2020 will reach a projected size of US$46.6 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$31.7 Million by the year 2027.

Select Competitors (Total 33 Featured) -

  • 10x Genomics

  • Advanced Cell Diagnostics, Inc. (ACD)

  • Cartana AB

  • Dovetail Genomics

  • Horizon Discovery Group plc

  • Illumina, Inc.

  • NanoString Technologies,

  • Readcoor, inc.

  • S2 Genomics, Inc.

  • Seven Bridges Genomic




Read the full report: https://www.reportlinker.com/p06032958/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Global Competitor Market Shares
Spatial Genomics and Transcriptomics Competitor Market Share
Scenario Worldwide (in %): 2020E
Global Competitor Market Shares by Segment

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Spatial Genomics
and Transcriptomics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ for Years 2020
through 2027 and % CAGR

Table 2: World Historic Review for Spatial Genomics and
Transcriptomics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ for Years 2012
through 2019 and % CAGR

Table 3: World 15-Year Perspective for Spatial Genomics and
Transcriptomics by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Consumables by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Consumables by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Consumables by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Instruments by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2020 through 2027 and % CAGR

Table 8: World Historic Review for Instruments by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Instruments by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Software by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Software by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ for Years 2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Software by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 13: World Current & Future Analysis for Translational
Research by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2020 through 2027 and
% CAGR

Table 14: World Historic Review for Translational Research by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Translational Research
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Academic
Customers by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ for Years 2020 through 2027 and
% CAGR

Table 17: World Historic Review for Academic Customers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Academic Customers by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
Market Analytics
Table 22: USA Current & Future Analysis for Spatial Genomics
and Transcriptomics by Product - Consumables, Instruments and
Software - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027 and % CAGR

Table 23: USA Historic Review for Spatial Genomics and
Transcriptomics by Product - Consumables, Instruments and
Software Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 24: USA 15-Year Perspective for Spatial Genomics and
Transcriptomics by Product - Percentage Breakdown of Value
Sales for Consumables, Instruments and Software for the Years
2012, 2020 & 2027

Table 25: USA Current & Future Analysis for Spatial Genomics
and Transcriptomics by End-Use - Translational Research,
Academic Customers and Other End-Uses - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 26: USA Historic Review for Spatial Genomics and
Transcriptomics by End-Use - Translational Research, Academic
Customers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 27: USA 15-Year Perspective for Spatial Genomics and
Transcriptomics by End-Use - Percentage Breakdown of Value
Sales for Translational Research, Academic Customers and Other
End-Uses for the Years 2012, 2020 & 2027

CANADA
Table 28: Canada Current & Future Analysis for Spatial Genomics
and Transcriptomics by Product - Consumables, Instruments and
Software - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027 and % CAGR

Table 29: Canada Historic Review for Spatial Genomics and
Transcriptomics by Product - Consumables, Instruments and
Software Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 30: Canada 15-Year Perspective for Spatial Genomics and
Transcriptomics by Product - Percentage Breakdown of Value
Sales for Consumables, Instruments and Software for the Years
2012, 2020 & 2027

Table 31: Canada Current & Future Analysis for Spatial Genomics
and Transcriptomics by End-Use - Translational Research,
Academic Customers and Other End-Uses - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 32: Canada Historic Review for Spatial Genomics and
Transcriptomics by End-Use - Translational Research, Academic
Customers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 33: Canada 15-Year Perspective for Spatial Genomics and
Transcriptomics by End-Use - Percentage Breakdown of Value
Sales for Translational Research, Academic Customers and Other
End-Uses for the Years 2012, 2020 & 2027

JAPAN
Table 34: Japan Current & Future Analysis for Spatial Genomics
and Transcriptomics by Product - Consumables, Instruments and
Software - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027 and % CAGR

Table 35: Japan Historic Review for Spatial Genomics and
Transcriptomics by Product - Consumables, Instruments and
Software Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 36: Japan 15-Year Perspective for Spatial Genomics and
Transcriptomics by Product - Percentage Breakdown of Value
Sales for Consumables, Instruments and Software for the Years
2012, 2020 & 2027

Table 37: Japan Current & Future Analysis for Spatial Genomics
and Transcriptomics by End-Use - Translational Research,
Academic Customers and Other End-Uses - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 38: Japan Historic Review for Spatial Genomics and
Transcriptomics by End-Use - Translational Research, Academic
Customers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 39: Japan 15-Year Perspective for Spatial Genomics and
Transcriptomics by End-Use - Percentage Breakdown of Value
Sales for Translational Research, Academic Customers and Other
End-Uses for the Years 2012, 2020 & 2027

CHINA
Table 40: China Current & Future Analysis for Spatial Genomics
and Transcriptomics by Product - Consumables, Instruments and
Software - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027 and % CAGR

Table 41: China Historic Review for Spatial Genomics and
Transcriptomics by Product - Consumables, Instruments and
Software Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 42: China 15-Year Perspective for Spatial Genomics and
Transcriptomics by Product - Percentage Breakdown of Value
Sales for Consumables, Instruments and Software for the Years
2012, 2020 & 2027

Table 43: China Current & Future Analysis for Spatial Genomics
and Transcriptomics by End-Use - Translational Research,
Academic Customers and Other End-Uses - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 44: China Historic Review for Spatial Genomics and
Transcriptomics by End-Use - Translational Research, Academic
Customers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 45: China 15-Year Perspective for Spatial Genomics and
Transcriptomics by End-Use - Percentage Breakdown of Value
Sales for Translational Research, Academic Customers and Other
End-Uses for the Years 2012, 2020 & 2027

EUROPE
Market Facts & Figures
Market Analytics
Table 46: Europe Current & Future Analysis for Spatial Genomics
and Transcriptomics by Geographic Region - France, Germany,
Italy, UK and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ for Years 2020 through 2027 and % CAGR

Table 47: Europe Historic Review for Spatial Genomics and
Transcriptomics by Geographic Region - France, Germany, Italy,
UK and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ for Years 2012 through 2019 and % CAGR

Table 48: Europe 15-Year Perspective for Spatial Genomics and
Transcriptomics by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK and Rest of Europe
Markets for Years 2012, 2020 & 2027

Table 49: Europe Current & Future Analysis for Spatial Genomics
and Transcriptomics by Product - Consumables, Instruments and
Software - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027 and % CAGR

Table 50: Europe Historic Review for Spatial Genomics and
Transcriptomics by Product - Consumables, Instruments and
Software Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 51: Europe 15-Year Perspective for Spatial Genomics and
Transcriptomics by Product - Percentage Breakdown of Value
Sales for Consumables, Instruments and Software for the Years
2012, 2020 & 2027

Table 52: Europe Current & Future Analysis for Spatial Genomics
and Transcriptomics by End-Use - Translational Research,
Academic Customers and Other End-Uses - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 53: Europe Historic Review for Spatial Genomics and
Transcriptomics by End-Use - Translational Research, Academic
Customers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 54: Europe 15-Year Perspective for Spatial Genomics and
Transcriptomics by End-Use - Percentage Breakdown of Value
Sales for Translational Research, Academic Customers and Other
End-Uses for the Years 2012, 2020 & 2027

FRANCE
Table 55: France Current & Future Analysis for Spatial Genomics
and Transcriptomics by Product - Consumables, Instruments and
Software - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027 and % CAGR

Table 56: France Historic Review for Spatial Genomics and
Transcriptomics by Product - Consumables, Instruments and
Software Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 57: France 15-Year Perspective for Spatial Genomics and
Transcriptomics by Product - Percentage Breakdown of Value
Sales for Consumables, Instruments and Software for the Years
2012, 2020 & 2027

Table 58: France Current & Future Analysis for Spatial Genomics
and Transcriptomics by End-Use - Translational Research,
Academic Customers and Other End-Uses - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 59: France Historic Review for Spatial Genomics and
Transcriptomics by End-Use - Translational Research, Academic
Customers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 60: France 15-Year Perspective for Spatial Genomics and
Transcriptomics by End-Use - Percentage Breakdown of Value
Sales for Translational Research, Academic Customers and Other
End-Uses for the Years 2012, 2020 & 2027

GERMANY
Table 61: Germany Current & Future Analysis for Spatial
Genomics and Transcriptomics by Product - Consumables,
Instruments and Software - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR

Table 62: Germany Historic Review for Spatial Genomics and
Transcriptomics by Product - Consumables, Instruments and
Software Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 63: Germany 15-Year Perspective for Spatial Genomics and
Transcriptomics by Product - Percentage Breakdown of Value
Sales for Consumables, Instruments and Software for the Years
2012, 2020 & 2027

Table 64: Germany Current & Future Analysis for Spatial
Genomics and Transcriptomics by End-Use - Translational
Research, Academic Customers and Other End-Uses - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR

Table 65: Germany Historic Review for Spatial Genomics and
Transcriptomics by End-Use - Translational Research, Academic
Customers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 66: Germany 15-Year Perspective for Spatial Genomics and
Transcriptomics by End-Use - Percentage Breakdown of Value
Sales for Translational Research, Academic Customers and Other
End-Uses for the Years 2012, 2020 & 2027

ITALY
Table 67: Italy Current & Future Analysis for Spatial Genomics
and Transcriptomics by Product - Consumables, Instruments and
Software - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027 and % CAGR

Table 68: Italy Historic Review for Spatial Genomics and
Transcriptomics by Product - Consumables, Instruments and
Software Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 69: Italy 15-Year Perspective for Spatial Genomics and
Transcriptomics by Product - Percentage Breakdown of Value
Sales for Consumables, Instruments and Software for the Years
2012, 2020 & 2027

Table 70: Italy Current & Future Analysis for Spatial Genomics
and Transcriptomics by End-Use - Translational Research,
Academic Customers and Other End-Uses - Independent Analysis of
Annual Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 71: Italy Historic Review for Spatial Genomics and
Transcriptomics by End-Use - Translational Research, Academic
Customers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 72: Italy 15-Year Perspective for Spatial Genomics and
Transcriptomics by End-Use - Percentage Breakdown of Value
Sales for Translational Research, Academic Customers and Other
End-Uses for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 73: UK Current & Future Analysis for Spatial Genomics and
Transcriptomics by Product - Consumables, Instruments and
Software - Independent Analysis of Annual Sales in US$ for the
Years 2020 through 2027 and % CAGR

Table 74: UK Historic Review for Spatial Genomics and
Transcriptomics by Product - Consumables, Instruments and
Software Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 75: UK 15-Year Perspective for Spatial Genomics and
Transcriptomics by Product - Percentage Breakdown of Value
Sales for Consumables, Instruments and Software for the Years
2012, 2020 & 2027

Table 76: UK Current & Future Analysis for Spatial Genomics and
Transcriptomics by End-Use - Translational Research, Academic
Customers and Other End-Uses - Independent Analysis of Annual
Sales in US$ for the Years 2020 through 2027 and % CAGR

Table 77: UK Historic Review for Spatial Genomics and
Transcriptomics by End-Use - Translational Research, Academic
Customers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 78: UK 15-Year Perspective for Spatial Genomics and
Transcriptomics by End-Use - Percentage Breakdown of Value
Sales for Translational Research, Academic Customers and Other
End-Uses for the Years 2012, 2020 & 2027

REST OF EUROPE
Table 79: Rest of Europe Current & Future Analysis for Spatial
Genomics and Transcriptomics by Product - Consumables,
Instruments and Software - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR

Table 80: Rest of Europe Historic Review for Spatial Genomics
and Transcriptomics by Product - Consumables, Instruments and
Software Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 81: Rest of Europe 15-Year Perspective for Spatial
Genomics and Transcriptomics by Product - Percentage Breakdown
of Value Sales for Consumables, Instruments and Software for
the Years 2012, 2020 & 2027

Table 82: Rest of Europe Current & Future Analysis for Spatial
Genomics and Transcriptomics by End-Use - Translational
Research, Academic Customers and Other End-Uses - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR

Table 83: Rest of Europe Historic Review for Spatial Genomics
and Transcriptomics by End-Use - Translational Research,
Academic Customers and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2019 and
% CAGR

Table 84: Rest of Europe 15-Year Perspective for Spatial
Genomics and Transcriptomics by End-Use - Percentage Breakdown
of Value Sales for Translational Research, Academic Customers
and Other End-Uses for the Years 2012, 2020 & 2027

ASIA-PACIFIC
Table 85: Asia-Pacific Current & Future Analysis for Spatial
Genomics and Transcriptomics by Product - Consumables,
Instruments and Software - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR

Table 86: Asia-Pacific Historic Review for Spatial Genomics and
Transcriptomics by Product - Consumables, Instruments and
Software Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 87: Asia-Pacific 15-Year Perspective for Spatial Genomics
and Transcriptomics by Product - Percentage Breakdown of Value
Sales for Consumables, Instruments and Software for the Years
2012, 2020 & 2027

Table 88: Asia-Pacific Current & Future Analysis for Spatial
Genomics and Transcriptomics by End-Use - Translational
Research, Academic Customers and Other End-Uses - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR

Table 89: Asia-Pacific Historic Review for Spatial Genomics and
Transcriptomics by End-Use - Translational Research, Academic
Customers and Other End-Uses Markets - Independent Analysis of
Annual Sales in US$ for Years 2012 through 2019 and % CAGR

Table 90: Asia-Pacific 15-Year Perspective for Spatial Genomics
and Transcriptomics by End-Use - Percentage Breakdown of Value
Sales for Translational Research, Academic Customers and Other
End-Uses for the Years 2012, 2020 & 2027

REST OF WORLD
Table 91: Rest of World Current & Future Analysis for Spatial
Genomics and Transcriptomics by Product - Consumables,
Instruments and Software - Independent Analysis of Annual Sales
in US$ for the Years 2020 through 2027 and % CAGR

Table 92: Rest of World Historic Review for Spatial Genomics
and Transcriptomics by Product - Consumables, Instruments and
Software Markets - Independent Analysis of Annual Sales in US$
for Years 2012 through 2019 and % CAGR

Table 93: Rest of World 15-Year Perspective for Spatial
Genomics and Transcriptomics by Product - Percentage Breakdown
of Value Sales for Consumables, Instruments and Software for
the Years 2012, 2020 & 2027

Table 94: Rest of World Current & Future Analysis for Spatial
Genomics and Transcriptomics by End-Use - Translational
Research, Academic Customers and Other End-Uses - Independent
Analysis of Annual Sales in US$ for the Years 2020 through 2027
and % CAGR

Table 95: Rest of World Historic Review for Spatial Genomics
and Transcriptomics by End-Use - Translational Research,
Academic Customers and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ for Years 2012 through 2019 and
% CAGR

Table 96: Rest of World 15-Year Perspective for Spatial
Genomics and Transcriptomics by End-Use - Percentage Breakdown
of Value Sales for Translational Research, Academic Customers
and Other End-Uses for the Years 2012, 2020 & 2027

IV. COMPETITION

Total Companies Profiled: 33
Read the full report: https://www.reportlinker.com/p06032958/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001